文献速递肾小球疾病急性肾损伤

ANCA相关性肾血管炎死亡预测评分

A predictive mortality score in ANCA-associated renal vasculitis.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

本研究基于Maine-Anjou登记中228例ANCA相关性肾小球肾炎(AAV-GN)患者构建了死亡预测评分DANGER,包含年龄、高血压或心脏病史、肌酐和血红蛋白四个成分。

要点

  • DANGER评分含年龄、高血压或心脏病史、肌酐、血红蛋白四个预测因子。
  • 新评分在开发队列和验证队列中预测死亡性能均优于既往评分。
  • 仅五因子评分和日本血管炎活动评分在AAV-GN中预测死亡表现良好。

核心结论

  • DANGER评分可能有助于预测AAV-GN患者的死亡风险,但需在不同人群中验证以明确其辅助临床决策的作用。

研究设计与样本

  • 多中心研究纳入自2000年1月起在四家肾内科中心诊断的AAV-GN患者(Maine-Anjou AAV-GN登记),共228例用于构建新评分。

主要发现

  • 新评分包含与死亡最相关的四个成分:年龄、高血压或心脏病史、诊断时肌酐和血红蛋白水平。
  • 194例患者有全部数据用于评估新评分与现有评分的性能。
  • 新评分在开发队列和验证队列中预测死亡的性能均优于既往评分。
  • 在测试的评分中,仅五因子评分(Five-Factor Score)和日本血管炎活动评分(Japanese Vasculitis Activity Score)在AAV-GN中预测死亡表现良好。

关键数值与推荐

  • 新评分纳入年龄、高血压或心脏病史、肌酐和血红蛋白四个成分。
  • 新评分性能评估基于194例有完整数据的患者。

临床怎么用

  • DANGER评分可用于AAV-GN患者诊断时死亡风险评估,辅助临床决策。
  • 需在不同人群中进一步验证以明确其临床作用。

局限性

  • 新评分需在不同人群中验证以明确其作用。
  • 研究基于特定登记队列,外推性需进一步确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several scores have been developed to predict mortality at anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) diagnosis. Their prognostic value in Caucasian patients with kidney involvement (AAV-GN) remains uncertain as none has been developed in this specific population. We aimed to propose a novel and more accurate score specific for them. METHODS: This multicentric study included patients diagnosed with AAV-GN since January 2000 in four nephrology centers (recorded in the Maine-Anjou AAV-GN Registry). Existing scores and baseline characteristics were assessed at diagnosis before any therapeutic intervention. A multivariable analysis was performed to build a new predictive score for death. Its prognosis performance (area under receiving operating curve and C-index) and accuracy (Brier score) was compared with existing scores. One hundred and eighty-five patients with AAV-GN from the RENVAS registry were used as a validation cohort. RESULTS: A total of 228 patients with AAV-GN from the Maine-Anjou registry were included to build the new score. It included the four components most associated with death: age, history of hypertension or cardiac disease, creatinine and hemoglobin levels at diagnosis. Overall, 194 patients had all the data available to determine the performance of the new score and existing scores. The new score performed better than the previous ones in the development and in the validation cohort. Among the scores tested, only Five-Factor Score and Japanese Vasculitis Activity Score had good performance in predicting death in AAV-GN. CONCLUSIONS: This original score, named DANGER (Death in ANCA Glomerulonephritis-Estimating the Risk), may be useful to predict the risk of death in AAV-GN patients. Validation in different populations is needed to clarify its role in assisting clinical decisions.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Fage N, Quéméneur T, Riou J, et al. A predictive mortality score in ANCA-associated renal vasculitis. Nephrol Dial Transplant. 2024. PMID: 38327221. doi:10.1093/ndt/gfae035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。